SINGAPORE (Jan 15): Venture Corp’s performance this year could be dragged by a disappointing FY20 revenue guidance by US biotechnology equipment manufacturer Illumina – its major customer – according to CGS-CIMB Research.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

Subscribe